Difference between revisions of "Aminoglutethimide (Cytadren)"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
'''This medication is no longer commercially available''' | '''This medication is no longer commercially available''' | ||
==General information== | ==General information== | ||
| − | Class: Inhibitor of adrenalcortical steroid synthesis, blocks conversion of cholesterol to pregnenolone and subsequent synthesis of adrenal steroids, has aromatase inhibitor activity<ref name="insert">[http://hemonc.org/docs/chemotherapypackageinsert/aminoglutethimide.pdf Aminoglutethimide (Cytadren) package insert (locally hosted backup)]</ref> | + | Class/mechanism: Inhibitor of adrenalcortical steroid synthesis, blocks conversion of cholesterol to pregnenolone and subsequent synthesis of adrenal steroids, has aromatase inhibitor activity<ref name="insert">[http://hemonc.org/docs/chemotherapypackageinsert/aminoglutethimide.pdf Aminoglutethimide (Cytadren) package insert (locally hosted backup)]</ref> |
<br>Route: PO | <br>Route: PO | ||
<br>Extravasation: n/a | <br>Extravasation: n/a | ||
Revision as of 06:42, 29 November 2011
This medication is no longer commercially available
General information
Class/mechanism: Inhibitor of adrenalcortical steroid synthesis, blocks conversion of cholesterol to pregnenolone and subsequent synthesis of adrenal steroids, has aromatase inhibitor activity[1]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].